Πολιτικές ανάπτυξης και προώθησης των γενόσημων φαρμάκων στην Ελλάδα
Policies for the development and promotion of generic drugs in Greece
View/ Open
Keywords
Γενόσημα φάρμακα ; Μονάδες υγείας ; Ζήτηση ; Οικονομική κρίση ; Πρωτότυπα φάρμακαAbstract
Generic medicines, although used in the rest of Europe more widely during the last century, have been introduced only in the last decade in Greece as substitutes for prototypes. While it is scientifically proven and based on laboratory tests that general concepts are not only safe but also life - equivalent to prototypes, Greek patients and consumers remain cautious about their use. One main reason seems to be that they were screened and promoted as part of the policy uncertainty followed by Greece from 2010 onwards and an alternative for patients. Based on available studies, it is found that generic drugs in the country have a significantly low level of penetration, while patients feel that their use is linked to the desire of doctors and the state to exploit themselves and gain the same benefit. There is, therefore, a crisis of trust between citizens and institutions.
This paper attempts to present all the specific issues related to consumption or, a fortiori, the lack of mood for consumption of generic drugs in Greece today. The method used draws data from the theory of management of the overall quality combined with the health sciences. Using the SWOT analysis and programming method, a plan is created that proposes a realistic and sustainable strategy for better acceptance and increased use of generic consumption in Greece.
The number of consumers and doctors remains unchanged, and there is no reference to the attitude of the mass media in Greece to generic medicines. Also, the study has not been purely applied to a theoretical analysis. Instead, a limited survey (n = 61), which is quantitative (questionnaires) and the results of the survey, was conducted for the purpose of its preparation and to highlight the most modern trends in society and the current attitudes of the general public towards generic medicines. presented in the practical / research part of the thesis.
The main findings of the work are that the Greeks are largely aware of the properties and uses of generic drugs and yet, however, they are not, as a whole, positively related to them. It is also observed that a large proportion of the population was informed from the outset about generic medicines by the media and the internet, which seems to be linked to their views on generic, their strongly negative attitudes towards them and the more general unwillingness to take them. However, there is no direct correlation of their attitude with their individual characteristics.